Preclinical Toxicology Study Report & Data Integration
Synthesize preclinical toxicology data into GLP-compliant regulatory reports
What You Can Do
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
Features
integrates clinical pathology, histopathology, organ weights, and mortality into unified safety assessment
identifies no-observed-adverse-effect levels with transparent dose-response justification across mixed signals
translates preclinical findings into human-equivalent doses and quantified hazard characterization
evaluates recovery vs. non-recovery observations to assess effect persistence and potential clinical risk
identifies and explains biological mechanisms behind strain, species, or sex differences
produces Results & Discussion text formatted for FDA/EMA briefing packages with defensible conclusions
highlights missing dose groups, outliers, or conflicting signals requiring investigation before report finalization
proposes biologically plausible explanations linking organ-level findings to systemic effects
Example Output
Example 1: 28-Day Rat Study Integration
- Input: Liver weight +15% at high dose; ALT/AST elevated 2–3× at high and mid doses; centrilobular hepatocyte hypertrophy at high dose; normal recovery at 14-day post-study checkpoint
- Output: "Liver hypertrophy at high dose (≥150 mg/kg) was associated with mild transaminase elevation and reversible histologic change (centrilobular hepatocyte hypertrophy), consistent with adaptive enzyme induction. Recovery observed post-study indicates non-progressive effect. NOAEL: 50 mg/kg; LOAEL: 150 mg/kg."
Example 2: Dog Study with Sex Difference
- Input: Anemia (Hgb drop 12%) in females at high dose; males unaffected; mild bone marrow hypoplasia in one female; kidney tubular protein casts in both sexes at mid and high dose
- Output: "Female-specific anemia at ≥300 mg/kg, accompanied by bone marrow hypoplasia in one animal, suggests sex-dependent hematotoxicity. Kidney findings (tubular casts) appeared in both sexes, indicating common nephrotoxic potential. Safety margin calculation applies female-specific LOAEL (300 mg/kg) with 10-fold inter-species adjustment."
Example 3: Chronic Study Hazard Summary
- Output table: Organ system | Finding | Dose (mg/kg) | Reversibility | Mechanism | Regulatory Impact
What's Included
- SKILL.md: complete instruction file with data integration workflow, NOAEL/LOAEL decision trees, and regulatory compliance checkpoints
- Multi-endpoint consolidation template: structured worksheet mapping clinical pathology, histopathology, organ weights, and clinical observations into unified findings table
- NOAEL/LOAEL determination framework: step-by-step logic for identifying thresholds across mixed dose-response signals with transparency
- Safety margin calculation checklist: formulae and species/sex adjustment factors (FDA guidance-aligned) for human-equivalent dose translation
- Results & Discussion outline: pre-formatted sections (Methods summary, Findings by organ system, NOAEL/LOAEL justification, Reversibility assessment, Hazard characterization) ready for regulatory submission
Who It's For
- Preclinical toxicologists — synthesizing study data into regulatory-grade reports for acute, subacute, and chronic safety assessments
- IND-enabling program leads — consolidating findings from multiple toxicology studies to support investigational new drug applications
- Drug safety scientists — translating organ-level findings into human risk assessment and hazard characterization for briefing packages
- Regulatory affairs specialists — preparing preclinical sections of FDA submissions (IND, NDA, IMPD) with defensible NOAEL/LOAEL conclusions
- Contract research organization (CRO) report writers — standardizing multi-study data synthesis and reducing manual narrative generation time
Best For
- 28–90-day repeat-dose toxicology studies — rat and dog safety assessment with complex, multi-parameter datasets
- NOAEL/LOAEL determination — translating mixed dose-response signals into justified threshold identification
- Reversibility and recovery assessment — evaluating post-study observation data to assess effect persistence and potential clinical risk
- Species or sex-specific finding interpretation — explaining biological mechanisms behind strain, species, or sex differences
- Regulatory briefing document generation — producing Results & Discussion sections that satisfy FDA/EMA technical review standards
You might also like
Claude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
You systematically analyze workstations and work tasks for ergonomic hazards using industry-standard assessment methods (RULA, NIOSH, ISO 11228). You receive quantified risk scores, pinpointed hazard identification, and prioritized mitigation recommendations ranked by impact and feasibility. You can generate compliance-ready documentation and implement targeted interventions to reduce musculoskeletal injury risk.
by kody-w
Conduct comprehensive job risk assessments in minutes, generate detailed task analysis reports with biomechanical findings, and develop prioritized ergonomic interventions backed by OSHA and NIOSH guidelines. You'll identify risk factors, quantify hazard severity, and produce actionable recommendations that reduce worker injury rates and improve compliance documentation.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
Analyze your power system topology, coordinate protective devices for optimal selectivity and speed, and generate comprehensive arc flash hazard analyses compliant with IEEE 1584. You get fault current calculations, device coordination plots, and hazard risk assessments that guide equipment upgrades and safety training.
by kody-w
You can rapidly diagnose why your solid dose formulations are failing—whether due to poor flowability, insufficient hardness, moisture sensitivity, dissolution issues, or API degradation. The skill walks you through structured root-cause analysis, maps chemical interactions between your drug substance and excipients across pH, temperature, and moisture conditions, then prioritizes excipient replacements based on regulatory precedent and manufacturing feasibility. You'll document all decisions with clear rationale ready for CMC submissions.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-w